In this episode, Professors Edoardo Midena (Padua University Hospital) and Reinier Schlingemann (Amsterdam UMC) chair a discussion around some of the hot topics in the subspecialty field of diabetic retinopathy. Joined by Professors Jennifer Sun (Joslin Diabetes Center, Harvard Medical School) and Jakob Grauslund (University of Southern Denmark), they discuss:

 

- The treatment of non-proliferative diabetic retinopathy with anti-VEGF intravitreal injections

 

- Faricimab, a new drug for the treatment of diabetic macular edema. The rationale and preliminary data

 

- Artificial intelligence in the screening of diabetic retinopathy: pearls and pitfalls